Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 10;10(9):e0135665.
doi: 10.1371/journal.pone.0135665. eCollection 2015.

Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State

Affiliations

Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State

Fianne L P Sips et al. PLoS One. .

Abstract

In metabolic diseases such as Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease, the systemic regulation of postprandial metabolite concentrations is disturbed. To understand this dysregulation, a quantitative and temporal understanding of systemic postprandial metabolite handling is needed. Of particular interest is the intertwined regulation of glucose and non-esterified fatty acids (NEFA), due to the association between disturbed NEFA metabolism and insulin resistance. However, postprandial glucose metabolism is characterized by a dynamic interplay of simultaneously responding regulatory mechanisms, which have proven difficult to measure directly. Therefore, we propose a mathematical modelling approach to untangle the systemic interplay between glucose and NEFA in the postprandial period. The developed model integrates data of both the perturbation of glucose metabolism by NEFA as measured under clamp conditions, and postprandial time-series of glucose, insulin, and NEFA. The model can describe independent data not used for fitting, and perturbations of NEFA metabolism result in an increased insulin, but not glucose, response, demonstrating that glucose homeostasis is maintained. Finally, the model is used to show that NEFA may mediate up to 30-45% of the postprandial increase in insulin-dependent glucose uptake at two hours after a glucose meal. In conclusion, the presented model can quantify the systemic interactions of glucose and NEFA in the postprandial state, and may therefore provide a new method to evaluate the disturbance of this interplay in metabolic disease.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: AstraZeneca provided support in the form of salary for author EN. This did not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The remaining authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Overview.
Overview of the workflow: model (Fig 2), model calibration with clamp simulations (Figs 3 and 4) and oral challenge simulations (Fig 5), comparison of the calibrated model with independent data (Fig 6), analysis of model response to NEFA perturbations (Fig 7), and quantification of NEFA regulation in the meal response (Fig 8).
Fig 2
Fig 2. Mathematical model.
The mathematical model of systemic glucose (left), insulin (middle) and NEFA (right) metabolism consists of a total of 18 differential equations. Glucose concentrations are determined by glucose rate of appearance (Ra), endogenous glucose production (EGP), insulin dependent (U id) and independent (U ii) glucose uptake and–if applicable–renal excretion (E). Plasma NEFA dynamics are described in Eqs 3–7. In the model, glucose enters the system via simulated ingestion in Q sto1, and lipid appearance is simulated by using the measured plasma TG concentration to calculate fatty acid spillover. For full model equations, we refer to S2 File. Matlab implementation and simulation files are provided as S3 File.
Fig 3
Fig 3. Clamp datasets: experimental data and simulation results.
Measurements from DCLAMP1 (hyperinsulinemic, euglycemic clamp) [32] (A,B, red errorbars) and DCLAMP2 [33] (C,D, red errorbars) with superimposed model outputs. The simulation represents the parameter set in Ssel that corresponds to a minimal value for VEGP. A. Mean EGP as measured over the final half of a 360 minute clamp with low, medium and high NEFA concentration. B. Total glucose uptake (conditions and measurement time as in A). C. EGP measured during the final 60 minutes of the 120 minute clamp in experiments of group C that underwent an eu-insulinemic, hyperglycemic clamp with a saline infusion (C-) and with a combined intralipid and heparin infusion (C+). D. Total glucose uptake as in C, for experiments with a hyperinsulinemic euglycemic clamp (group A-, A+), hyperinsulinemic, hyperglycemic clamp (group B-, B+), and an eu-insulinemic, hyperglycemic clamp (group C- and C+). A short summary of the implementation in the model is provided in the Materials and Methods; full details of implementation can be found in S1 File.
Fig 4
Fig 4. Model calibration on clamp data.
To investigate propagation of parameter uncertainty in predictions and analyses a collection of parameter sets was selected. Measurements from DCLAMP1 (hyperinsulinemic, euglycemic clamp) [32] (A,B, red errorbars) and DCLAMP2 [33] (C,D, red errorbars) with superimposed model outputs as in Fig 3. Here, simulations representing the complete collection of selected parameter sets (Ssel) are shown, depictured as dots shaded from dark green for poor fits of EGP (high values of VEGP) to light green for low VEGP. We note in C, that not all parameter sets from Ssel describe the data, and that a bad correspondence of the simulations in A and C is shown with dark green color.
Fig 5
Fig 5. Model calibration on meal responses.
Data from DMEAL [48] (red errorbars) and model simulations (Sext, grey curves; and Ssel, green shading as in Fig 4) in response to an OGTT (A) and an OFTT (B).
Fig 6
Fig 6. Model prediction–NEFA kinetics during a multi-step insulin infusion.
To verify general NEFA kinetics, a multi-step insulin infusion (Campbell et al. [53]) was modelled by fixing glucose (A) and insulin (B) to clamped concentrations. As TG was not measured, it was fixed at 1000 μM. The initial NEFA concentration was fixed at the measured value. (C) Simulated NEFA concentration, Ssel (shades of green, as in Fig 4) and measurements of the independent clamp dataset [53] (red errorbars).
Fig 7
Fig 7. Model analysis–glucose homeostasis.
Perturbations of NEFA metabolism affect the AUC of the glucose, insulin and NEFA responses to the OGTT. A-D. Overview of perturbation strategy. A. Original OGTT response model. B. Perturbed model. C. Perturbation by increasing the initial NEFA concentration (Pbas in the illustration). D. Perturbation by reducing the insulin dependent inhibition of lipolysis (Plip in the illustration). E-G-I. Relative change in AUC of NEFA (E), glucose (G) and insulin (I) in response to an increase in the initial concentration of NEFA. F-H-J. Relative change in AUC of NEFA (F), glucose (H) and insulin (J) in response to reduced insulin-dependent inhibition of lipolysis. Red markers represent individual simulation results per parameter set; the shaded area (dark red) gives the full range.
Fig 8
Fig 8. Model analysis—contribution of NEFA regulation in the postprandial glucose response.
A. Relative contribution of regulation by the NEFA-regulation term Nd1(t), on Uid during an OGTT, plotted at the time point where the absolute value of the NEFA regulation of Uid is maximal. B. Relative dependence of EGP suppression on the regulation by NEFA, plotted at the time point when the absolute NEFA-induced suppression is maximal. Colors indicate VEGP (green shading as in Fig 4). The individual results represent the parameter sets in Ssel.

Similar articles

Cited by

References

    1. Johanson EH, Jansson P-A, Gustafson B, Lönn L, Smith U, Taskinen M-R, et al. Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes. J Intern Med. 2004;255: 273–279. - PubMed
    1. Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, et al. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids. 2001;36: 1117–1124. - PubMed
    1. Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, et al. Treating Postprandial Hyperglycemia Does Not Appear to Delay Progression of Early Type 2 Diabetes The Early Diabetes Intervention Program. Diabetes Care. 2006;29: 2095–2101. doi: 10.2337/dc06-0061 - DOI - PubMed
    1. Lefebvre P, Scheen A. The postprandial state and risk of cardiovascular disease. Diabet Med. 1998; S63–68. - PubMed
    1. Borén J, Taskinen M-R, Adiels M. Kinetic studies to investigate lipoprotein metabolism. J Intern Med. 2012;271: 166–173. doi: 10.1111/j.1365-2796.2011.02497.x - DOI - PubMed

Publication types